Novan Announces Late-Breaking Abstract on Nitric Oxide Releasing Gel for Topical Treatment of Highly Contagious Skin Virus (Molluscum Contagiosum) Accepted for Presentation at American Academy of Dermatology’s (AAD) 2022 Annual Meeting

On March 24, 2022, Novan, Inc. (Nasdaq: NOVN), announced that data from its pivotal Phase 3 study of berdazimer gel 10.3% (SB206) for the treatment of molluscum contagiosum was selected for an oral presentation at a late-breaker session at the American Academy of Dermatology’s (AAD) 2022 Annual Meeting. Details of the abstract presentation are below:
Login Or Register To Read Full Story